Mentions
Extended reach
Total likes
Video views
AI synopsis
The entries reveal enthusiasm for the novel oral gene editing approach, with discussions highlighting its potential to transform colorectal cancer treatment, like mentions of boosting chemo-immunotherapy and targeting TRAP1. The tone varies from support to cautious optimism, with some users referencing specific biological mechanisms and the significance of the research's implications.
Most discussions indicate support or positive acknowledgment of the significance of the research, with some emphasizing its potential benefits.
Participants show high interest, referencing the innovation of the oral delivery system and its implications for future therapies.
The discussions demonstrate active engagement, with comments about mechanisms like TRAP1 and mitochondrial function, indicating varied depth of understanding.
Comments suggest the research could have meaningful effects on cancer treatment strategies, though some express cautious optimism rather than certainty.
『An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer』 Nature Nanotechnology 23 April 2025 ミトコンドリアシャペロン（TRAP1）にて制御 TRAP1遺伝子破壊 シクロフィリンDが移mPTPが開き 化学療法による腫瘍細胞壊死と免疫応答up https://t.co/BuVfFFUdXo
"An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer" Zhao K [..] Zhang X-Z. Nat Nanotechnol. 2025-04-23. https://t.co/s1xOsdqZ0w CRISPR-Cas9 KO TRAP1
An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer | Nature Nanotechnology https://t.co/WQMlxxM0Q1
An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer : https://t.co/hNLZK749oK
This video explores how disrupting mitochondrial TRAP1 can improve chemo-immunotherapy in colorectal cancer by boosting immune response and overcoming resistance, using innovative oral gene-editing nanoparticles.
Chemoresistance and immunosuppression hinder chemo-immunotherapy in colorectal cancer. Disrupting the mitochondrial chaperone protein TRAP1 enhances immune response and improves treatment efficacy via novel gene editing…
Chemoresistance and immunosuppression hinder chemo-immunotherapy in CRC. The video discusses an oral CRISPR-Cas9 system targeting TRAP1 gene to improve therapy by promoting tumor necrosis and immune activation, based on…
This video discusses how disrupting TRAP1, a mitochondrial chaperone, promotes tumor cell necrosis and boosts immune responses, improving chemo-immunotherapy efficacy in colorectal cancer using a novel oral gene editing…
Disrupting TRAP1 in tumor cells promotes necrosis and boosts immune responses by affecting mitochondrial function. An oral CRISPR-Cas9 system targeting TRAP1 enhances chemotherapy efficacy and stimulates anti-tumor…
This video discusses how disrupting the TRAP1 gene in tumor cells can promote necrosis and boost immune responses by affecting mitochondrial function, thereby improving chemo-immunotherapy effectiveness in colorectal…
An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer : https://t.co/hNLZK749oK
『An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer』 Nature Nanotechnology 23 April 2025 ミトコンドリアシャペロン（TRAP1）にて制御 TRAP1遺伝子破壊 シクロフィリンDが移mPTPが開き 化学療法による腫瘍細胞壊死と免疫応答up https://t.co/BuVfFFUdXo
"An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer" Zhao K [..] Zhang X-Z. Nat Nanotechnol. 2025-04-23. https://t.co/s1xOsdqZ0w CRISPR-Cas9 KO TRAP1
An orally administered gene editing nanoparticle boosts chemo-immunotherapy in colorectal cancer | Nature Nanotechnology https://t.co/WQMlxxM0Q1